The medication does not restrict specific foods, though dietary choices significantly influence treatment outcomes
Retatrutide is a synthetic 39-amino acid peptide classified as a triple agonist targeting GLP-1, GIP, and glucagon receptors
Even Hers, a telehealth brand built around women's health, presents semaglutide, tirzepatide, and liraglutide as general GLP-1 options without any female-specific dosing or efficacy data, according to its own peptides guide
Medical Conditions Preventing Injections Certain health conditions make injections risky: Severe bleeding disorders (hemophilia, severe thrombocytopenia) Anticoagulation therapy with high bleeding risk Skin conditions affecting multiple injection sites (psoriasis, eczema, scarring) Lymphedema affecting typical injection areas Religious or Cultural Considerations Some individuals have religious or cultural objections to: Self-injection practices Specific injection methods Needle use for non-medical emergencies If these beliefs are deeply held, oral medication provides an alternative while respecting personal values
Today, approximately 50% of all HF patients demonstrate preserved ejection fraction, and the prevalence of this condition continues to increases annually
